NOTCH and AKT Signalling Interact to Drive Mammary Tumour Heterogeneity

Liliana Ordonez1, Giusy Tornillo1, Howard Kendrick1

  • 1The European Cancer Stem Cell Research Institute, School of Biosciences, Cardiff University, Hadyn Ellis Building, Maindy Road, Cardiff CF24 4HQ, UK.

Cancers
|September 9, 2023
PubMed

Insights

The NOTCH pathway suppresses metaplastic adenosquamous carcinomas (ASQCs) in mouse mammary tumors. Loss of NOTCH1/2 alleles increases ASQCs, suggesting PI3K/AKT and NOTCH signaling interactions influence tumor type.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Research

Background:

  • Tumor heterogeneity influences therapeutic strategies and resistance mechanisms.
  • Mammary tumor histotype in mouse models depends on oncogenic alleles, cell type, and reproductive history, suggesting non-stochastic origins.
  • Signaling pathways play a critical role in determining reproducible differences in tumor histotype.

Purpose of the Study:

  • To investigate the role of the NOTCH signaling pathway in regulating mouse mammary tumor heterogeneity.
  • To determine the effect of NOTCH1 and NOTCH2 deletion on mammary tumor development and histotype.
  • To explore the relationship between NOTCH signaling, PI3K/AKT signaling, and the development of metaplastic adenosquamous carcinomas (ASQCs) and adenomyoepitheliomas (AMEs).

Main Methods:

  • Utilized genetically modified mouse models with conditional knockout alleles for Notch1 or Notch2.
  • Crossed these conditional knockout alleles into an established mouse mammary tumor model.
  • Analyzed tumor histotype, tumor-specific survival, and AKT signaling activation in the presence and absence of NOTCH alleles.

Main Results:

  • Deletion of Notch1/2 alleles did not impact tumor-specific survival.
  • Loss of NOTCH alleles led to a dose-dependent increase in metaplastic adenosquamous carcinomas (ASQCs).
  • ASQCs and adenomyoepitheliomas (AMEs) showed increased AKT signaling, irrespective of NOTCH status.

Conclusions:

  • The NOTCH pathway acts as a suppressor of the ASQC phenotype in mouse mammary tumors.
  • Increased PI3K/AKT signaling is significantly associated with ASQC and AME tumor development.
  • A model is proposed where PI3K/AKT and NOTCH signaling pathways interact to determine mouse mammary tumor histotype.

Related Concept Videos

Notch Signaling Pathway03:14

Notch Signaling Pathway

The Notch signaling pathway is a major intracellular signaling pathway that is highly conserved over a broad spectrum of metazoan species. It stands unique from other intracellular signaling mechanisms in animals because notch protein itself acts as the receptor as well as the primary signaling molecule.
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not...
4.3K
Role Of Notch Signalling In Intestinal Stem Cell Renewal01:12

Role Of Notch Signalling In Intestinal Stem Cell Renewal

Notch signaling was first discovered in Drosophila melanogaster, where it is involved in cell lineage differentiation. Notch signaling regulates the maintenance and differentiation of intestinal stem cells or ISCs by controlling the expression of atonal homolog 1 or Atoh1. Atoh1 directs cells to differentiate into secretory cells.
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
2.1K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
3.6K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.8K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.3K
Non-Canonical Wnt Signaling Pathways01:41

Non-Canonical Wnt Signaling Pathways

Wnt is a zygotic effect gene that is expressed during very early embryonic development. It regulates various processes in animals starting from early development through the adult stage, such as organogenesis in the embryo and maintenance of neuronal and blood stem cells. Wnt proteins can induce a wide variety of intracellular pathways depending upon the specific abilities of different Wnt ligands to form a complex with shared and cognate receptors in the presence of different co-receptors. The...
7.3K